A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

Clinical trial NCT07169578 · RECRUITING

Trial details

NCT number: NCT07169578
Sponsor: Hoffmann-La Roche
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimers Disease

Start date: 2025-09-17
Primary completion: 2028-06-07
Enrollment: 800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.